Published 2015 | Version v1
Journal article

Appropriateness criteria of FDG PET/CT in oncology

  • 1. Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital, Mumbai, Maharashtra (India)

Description

18Fluorine-2-fluoro-2-Deoxy-d-glucose (18F-FDG) positron emission tomography/computerized tomography (PET/CT) is a well-established functional imaging method widely used in oncology. In this article, we have incorporated the various indications for 18FDG PET/CT in oncology based on available evidence and current guidelines. Growing body of evidence for use of 18FDG PET/CT in select tumors is also discussed. This article attempts to give the reader an overview of the appropriateness of using 18F-FDG PET/CT in various malignancies

Availability note (English)

Available from http://dx.doi.org/10.4103/0971-3026.155823; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419439

Additional details

Publishing Information

Journal Title
Indian Journal of Radiology and Imaging - New Series (Print)
Journal Volume
25
Journal Issue
2
Journal Page Range
p. 88-101
ISSN
0971-3026

Optional Information

Notes
PMCID: PMC4419439; PMID: 25969632; PUBLISHER-ID: IJRI-25-88; OAI: oai:pubmedcentral.nih.gov:4419439; Copyright: (c) Indian Journal of Radiology and Imaging; This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.